{"id":"W2944341352","doi":"10.1007/s12282-019-00973-4","title":"A meta-analysis of clinical benefit rates for fulvestrant 500 mg vs. alternative endocrine therapies for hormone receptor-positive advanced breast cancer","year":2019,"lang":"en","type":"review","venue":"Breast Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"AstraZeneca; Amgen","keywords":"Fulvestrant; Medicine; Anastrozole; Internal medicine; Oncology; Odds ratio; Breast cancer; Cancer; Estrogen receptor; Tamoxifen","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_narrow","metaepi_broad"],"category_scores_codex":[0.0007682574,0.001824294,0.01633313,0.0008706474,0.0001648348,0.00005454003,0.0008000638,0.0005747477,0.001818573],"category_scores_gemma":[0.00006646948,0.001290472,0.01145927,0.001534773,0.0005505283,0.0003909123,0.0001455036,0.0008002863,0.00001383266],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008446487,"about_ca_system_score_gemma":0.001774787,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001063217,"about_ca_topic_score_gemma":0.000328568,"domain_scores_codex":[0.9919416,0.0002782587,0.003378366,0.002231853,0.0009143609,0.001255552],"domain_scores_gemma":[0.9899403,0.002029296,0.003696902,0.001433173,0.002443634,0.0004566695],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.006846582,0.0003373441,0.00007016535,0.006064859,0.3458329,0.000004618816,0.000179741,0.0001977677,0.00003850335,0.000201757,0.0001548519,0.6400709],"study_design_scores_gemma":[0.006168247,0.0006929627,0.001889486,0.003571322,0.5477986,0.0001450382,0.0001124998,0.0001171297,0.00005797792,0.0001095153,0.4380853,0.001251923],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001461944,0.8911932,0.001238142,0.001780688,0.0008587731,0.007485361,0.09716906,0.00009562024,0.00003298287],"genre_scores_gemma":[0.0005844649,0.9745312,0.003689274,0.0005931795,0.001771274,0.0140007,0.001956514,0.0004376541,0.002435721],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6388189,"threshold_uncertainty_score":0.9994502,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.165354414097557,"score_gpt":0.4697720474355399,"score_spread":0.3044176333379828,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}